Eli Lilly and Co. said Thursday its third-quarter profit rose 6 percent on strong sales of drugs such as its Cymbalta depression treatment, and it raised its outlook for the year.
From: www.jconline.com
Sales of Cymbalta fuel rise in Lilly profits
Posted by Ruslan Abuzant at 11:13 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment